Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.15.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.15.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.15.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.9.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.9.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FA.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FA.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ER.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ER.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ER.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ER.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17982.1US
CQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.11.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used